Domain |
Quality Indicator |
Facility |
State |
Facility rank (#1 is best) |
For the Quality Indicators below, a lower percentage is better. |
Psychosocial |
Worsening or serious resident behavior problems (LS) |
5.4 % |
8.4 % |
125 of
326 |
Psychosocial |
Prevalence of depressive symptoms (LS) |
3.3 % |
4.1 % |
166 of
325 |
Quality of Life |
Prevalence of physical restraints (LS) |
0.0 % |
0.0 % |
1 of
326 |
Continence |
Worsening or serious bowel incontinence (LS) |
26.8 % |
30.5 % |
119 of
326 |
Continence |
Worsening or serious bladder incontinence (LS) |
14.6 % |
29.9 % |
30 of
326 |
Continence |
Prevalence of occasional to full bowel incontinence without a toileting plan (LS) |
22.9 % |
93.9 % |
2 of
314 |
Continence |
Prevalence of occasional to full bladder incontinence without a toileting plan (LS) |
14.5 % |
84.8 % |
2 of
318 |
Continence |
Prevalence of indwelling catheter (LS) |
0.8 % |
2.3 % |
106 of
326 |
Infections |
Prevalence of urinary tract infections (LS) |
1.1 % |
2.9 % |
76 of
326 |
Infections |
Prevalence of infections (LS) |
4.8 % |
2.4 % |
277 of
324 |
Accidents |
Percent of residents experiencing one or more falls with major injury (LS) |
0.0 % |
0.7 % |
1 of
326 |
Nutrition |
Prevalence of unexplained weight loss (LS) |
2.4 % |
4.3 % |
81 of
326 |
Skin Care |
Prevalence of pressure sores in high risk residents (LS) |
1.7 % |
5.1 % |
32 of
322 |
Psychotropics |
Prevalence of anti-psychotics without a diagnosis of psychosis (LS) |
1.6 % |
9.0 % |
26 of
321 |
Functioning |
Worsening or serious functional dependence (LS) |
n/a |
|
n/a of
0 |
Functioning |
Worsening or serious mobility dependence (LS) |
n/a |
|
n/a of
0 |
Functioning |
Worsening or serious range of motion limitation (LS) |
4.6 % |
13.2 % |
39 of
323 |
Pain |
Percent of residents who self-report moderate to severe pain (LS) |
9.6 % |
14.7 % |
93 of
325 |
For the Quality Indicators below, a higher percentage is better. |
Functioning |
Walking as well or better than on a previous assessment (LS) |
n/a |
|
n/a of
0 |
(Date range:
October 1, 2023 to September 30, 2024) |